Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis
Diabetes Epidemiology and Management · 2026 · 21 · 100302
DOI: 10.1016/j.deman.2026.100302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Epidemiology and Management, 2026. Verfasst von Ricardo E T Navarrete und 5 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Navarrete, R. E. T., Fernandes, J., Fonseca, I., Silvano, J. L., Martins, L. S., & Sa, J. R. (2026). Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis. Diabetes Epidemiology and Management, 21, 100302. https://doi.org/10.1016/j.deman.2026.100302
Vancouver
Navarrete RET, Fernandes J, Fonseca I, Silvano JL, Martins LS, Sa JR. Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis. Diabetes Epidemiology and Management. 2026;21:100302. doi:10.1016/j.deman.2026.100302
BibTeX
@article{Navarrete2026,
author = {Navarrete, Ricardo E T and Fernandes, Joao and Fonseca, Isabel and Silvano, José Luis and Martins, La Salete and Sa, Joao Roberto},
title = {Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis},
journal = {Diabetes Epidemiology and Management},
year = {2026},
volume = {21},
pages = {100302},
doi = {10.1016/j.deman.2026.100302}
}
EUVIMED